SCHEMBL4773755

SCHEMBL4773755

O=C(Cl)c1cccoc1=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.45
ALOX15 P16050 1/20 0.45
CES2 O00748 1/20 0.43
CES1 P23141 1/20 0.43
CA1 P00915 1/20 0.41
CA9 Q16790 1/20 0.41
PTPN1 P18031 2/20 0.39
KMT2A Q03164 7/20 0.38
POLB P06746 4/20 0.38
MEN1 O00255 2/20 0.38
TDP1 Q9NUW8 2/20 0.38
THRB P10828 1/20 0.38
APEX1 P27695 1/20 0.38
RECQL P46063 1/20 0.38
PKM P14618 1/20 0.38
PTPN7 P35236 1/20 0.38
BLM P54132 1/20 0.38
ESR2 Q92731 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
KDM4E B2RXH2 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL259073 0.79 ALDH1A1 (0.52) ALDH1A1ALOX15CES2CES1CA1
SCHEMBL27642043 0.77 KMT2A (0.51) ALDH1A1CES2CES1CA1CA9
SCHEMBL1981395 0.77 ALDH1A1 (0.47) ALDH1A1CES2CES1CA1CA9
SCHEMBL28761620 0.74 ALDH1A1 (0.42) ALDH1A1ALOX15PTPN1KMT2APOLB
SCHEMBL1137507 0.72 MAPK1 (0.55) ALDH1A1ALOX15CA1CA9KMT2A
SCHEMBL10460465 0.72 AKR1C3 (0.55) ALDH1A1KMT2AMEN1TDP1PKM
SCHEMBL7752131 0.72 NPC1 (0.42) ALDH1A1ALOX15CES2CES1CA1
SCHEMBL422 0.72 ALDH1A1 (0.67) ALDH1A1ALOX15CES2CES1CA1
SCHEMBL109405 0.71
Hydrochloric Acid SCHEMBL4129676 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1309565-B1 HETEROCYCLIC MUTILIN ESTERS AND THEIR USE AS ANTIBACTERIALS SMITHKLINE BEECHAM PLC (GB) 2008-04-09 EP disclosed
US-6878704-B2 Heterocyclic mutilin esters and their use as antibacterials SMITHKLINE BEECHAM P.L.C. (GB) 2005-04-12 US disclosed
US-20040058937-A1 Heterocyclic mutilin esters and their use as antibacterials SMITHKLINE BEECHAM P.L.C. (GB) 2004-03-25 US disclosed
EP-1309565-A1 HETEROCYCLIC MUTILIN ESTERS AND THEIR USE AS ANTIBACTERIALS SMITHKLINE BEECHAM PLC (GB) 2003-05-14 EP disclosed
WO-2002012199-A1 HETEROCYCLIC MUTILIN ESTERS AND THEIR USE AS ANTIBACTERIALS SMITHKLINE BEECHAM P.L.C. (GB) 2002-02-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040058937-A1 Heterocyclic mutilin esters and their use as antibacterials MLN, MSH2, MRPL21 ALDH1A1 852/4885ALOX15 3555/4885CES2 3379/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.